Additionally, we generated RIE-1 cells that expressed K588M (TrkB KD), a kinase-inactive point-mutant of TrkB, to determine if the tyrosine kinase activity of TrkB is required to inhibit the tumor suppressor activity of TGF-β1 [18]. The gene discussed is NTRK2; the disease is neoplasm.